INNOVADERM CRO IS NOW INDERO.

Indero Named Best Employer by Mercer

Indero

Indero

Team of Experts

Author picture

[MONTREAL, December 9th, 2025]Indero, a global CRO specializing in dermatology and rheumatology, has been honored by Mercer, recognizing its excellence as an Employer of Choice. This distinction reflects Indero’s long-term commitment to building a workplace culture defined by trust, fairness, and meaningful employee experiences.

The Best Employers in Canada – Powered by Mercer certification program recognizes organizations that consistently deliver a positive and engaging employee experience, based on employee feedback. The degree of employee engagement is a crucial factor for both current and prospective clients and partners, since motivated and committed employees are more likely to excel in their roles and ensure the highest standards in the organization’s products and services. Formerly known as the Kincentric Best Employers , the program has highlighted Canada’s top workplaces for over 25 years and now benefits from Mercer’s expanded global reach and one of the most comprehensive employee experience databases in the world.

In today’s complex clinical research environment, the ability to attract and retain engaged, high-performing teams is essential. Indero’s recognition by Mercer affirms its strategic approach to human resources (HR); one that balances global consistency with local responsiveness, and operational rigor with cultural empathy.

“Being named an Employer of Choice is more than a milestone, it’s a reflection of how we listen, adapt, and invest in people,” said Yvon Leduc, Global Head of Human Resources. “It’s about creating the conditions for excellence, not just within HR, but across every function that contributes to our mission.”

At Indero, human resources play a central, strategic role. This acknowledgment reflects not just the work of the HR team, but also how employees feel about working at Indero, their motivation to do their best, and their desire to stay and advance in their careers. By actively listening to staff, promoting fairness, and streamlining operations, HR helps build a strong, collaborative culture that supports accuracy and long-term success, qualities that are vital in clinical research.

Ultimately, the recognition serves as a reminder that meaningful outcomes, whether in employee engagement or scientific advancement, are built on shared values and collective effort. Indero remains committed to cultivating a workplace where people thrive, and where purpose drives performance.

About Indero
Indero is a dual-focus CRO for dermatology and rheumatology, with over 25 years of experience in clinical research and trial delivery. Our full-service approach which includes everything from protocol design and patient recruitment to trial monitoring and biometrics provides biotech and pharmaceutical sponsors with the rigorous scientific foundation and tailored expertise their studies need to reach the finish line efficiently and effectively. With capabilities in North America, Europe, Latin America, and Asia-Pacific; vast, continuously growing relationships with investigators and patients; and a dedicated research clinic through which we design and execute our own studies, Indero is the ideal partner for clinical needs at global scale. 

Original Article: Business Wire

For more information:
Valerie Coveney
Communications Specialist
Indero
[email protected]

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte près de 30 ans d’expérience dans l’industrie pharmaceutique et CRO, s’étant distingué par son leadership exceptionnel, sa vision stratégique et son innovation. L’expertise de Jeff couvre des opérations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matière de création de valeur, de gestion des partenaires et d’opérations CRO ont toujours contribué au succès dans ses fonctions précédentes. Sous la direction de Jeff, Indero continue d’étendre ses capacités, faisant progresser les connaissances médicales et les nouvelles thérapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≤3 days, and lowers costs, helping teams make informed go/no-go decisions faster.